Out of Stock

Anthelios Spray SPF 30 with mexoryl sxD/C (125 ml/4 oz)

$26.50 USD

Out of stock

Product categories: Uncategorized,


La Roche Posay has discontinued Anthelios 30 Spray and has replaced it with Anthelios XL SPF 45 Spray. Anthelios XL 45 contains the added benefit of Mexoryl XL and Tinosorb S, giving you the ultimate in UVA and UVB protection.

 Anthelios Spray SPF 30 reduces the chance of premature skin aging.

Broad spectrum, high protection formula including Mexoryl SX (ecamsule) and Parsol 1789  spray for all skin types, yet especially recommended for combination to oily skin.
Easy to apply.
Non-greasy effect.
Non comedogenic.

For high SPF face protection consider using La Roche Posay’s Hydraphase UV. This is a lighter, yet hydrating formula that contains Mexoryl SX (SPF 30)

Not sure which Anthelios product is best for you? Click here.

Q: What is the difference between Mexoryl SX and Mexoryl XL?
A: Mexoryl SX is a water soluble form suitable for day wear sunscreen formulations. Mexoryl XL is an oil soluble form. Both offer effective protection against UVA and UVB rays.

For specific anti-aging products from La Roche Posay consider Active C (wrinkles and fine lines) or Redermic (deep wrinkles and loss of firmness)

To view our anti-aging department click here.


Apply 15-30 minutes before sun exposure. Reapply after swimming or excessive perspiration.


Active Ingredients: Octocrylene 10%, Titanium Dioxide 5.6%, Octisalate 5.0%, Avobenzone (Parsol 1789) 3.0%, Terephthalylidene Dicamphor Sulfonic Acid (Mexoryl SX)0.5%.
Inactive Ingredients: Aqua, Glycerin, Cyclohexasiloxane, Alcohol Denat, Propylene Glycol, Diglycol/CHDM/Isophtalates/SIP Copolymer, Alumina, Ethylhexyl Glycerin, Pentasodium Ehtylenediamine Tetramethylene Phosphonate, Polyacrylate-3, Silica, Tocopherol, Triethanolamine. .


For external use only. If skin irritation develops discontinue use


There are no reviews yet.

Be the first to review “Anthelios Spray SPF 30 with mexoryl sxD/C (125 ml/4 oz)”

Your email address will not be published. Required fields are marked *